Heart Disease Trial, Recruiting NCT06905405 Sponsor: Sheffield Teaching Hospitals NHS Foundation Trust Condition: Heart Disease
Back to Heart Disease

Heart Disease Trial, Recruiting

NCT06905405
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Adults aged 18 years or older, either male or female.
  • People who experience shortness of breath when physically active or exerting themselves.
  • People with a blood test result showing a heart stress marker called NTproBNP above 400 ng/L, measured while the heart is in a normal rhythm.
  • People whose heart ultrasound shows an enlarged left chamber of the heart, but whose heart function does not meet the current medical definitions of heart failure with reduced or preserved pumping ability (confirm with trial site for full technical details).

Who may not be able to join:

  • People who are unable to give informed consent to participate.
  • People with a history of a specific type of heart failure where the heart's pumping function is reduced (known as HFrEF).
  • People who have medical reasons that make a type of medication called SGLT2 inhibitors unsuitable for them — this includes a history of type 1 diabetes, a condition called ketoacidosis, a known allergy to SGLT2 inhibitors, current or planned use of SGLT2 inhibitors, or an active genital infection.
  • People who have an irregular heart rhythm condition called atrial fibrillation.
  • People who currently experience chest pain caused by reduced blood flow to the heart (known as angina).

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 8 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Sheffield Teaching Hospitals NHS Foundation Trust
Registry
ClinicalTrials.gov
Start date
5 August 2025
Est. completion
31 July 2027

Where this trial is recruiting

🇬🇧 United Kingdom

Primary endpoints

Primary Outcome

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 8 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov